Molecular HIV surveillance (MHS) provides data to monitor the prevalence of drug resistant strains of HIV, mutations associated with resistance to ART, and the distribution of HIV 1 sub-types among persons diagnosed with HIV. Virginia has currently received limited funding to begin building infrastructure for conducting molecular HIV surveillance activities. The main goals of molecular surveillance are: 1) to assess prevalence and trends in acquired and transmitted HIV drug resistance; 2) to evaluate HIV genetic diversity; and (3) to describe HIV transmission patterns for the purpose of evaluating the impact of HIV prevention strategies, guiding public health action, and enhancing the understanding of the burden of HIV in the United States.
The objectives of MHS are to:
VDH will be working with laboratories and medical providers to determine the best collection methods for these data and will be piloting collection of these data in 2013. For more information, please contact us.